Lithuanian national health authority contributing EHR interoperability and population health data governance to EU-wide health infrastructure projects.
The Lithuanian Ministry of Health is the national government authority responsible for health policy, legislation, and the governance of Lithuania's health system. In EU research projects, it contributes as a national competent authority — bringing regulatory access, health data governance, and the authority to commit national health information systems to cross-border frameworks. Both its H2020 engagements are Coordination and Support Actions, meaning its role is not to conduct research but to anchor EU-level initiatives to national policy realities: connecting European electronic health record standards to Lithuanian hospitals, and feeding national population health data into EU-wide research infrastructure. For consortium builders, the ministry's value is as the official national gateway to Lithuania's health data ecosystem.
In X-eHealth, the ministry represents Lithuania in building a common EU framework for exchanging EHRs, covering lab results, hospital discharge reports, medical imaging, and rare disease records.
In PHIRI, the ministry contributes national health data and governance authority to a European population health research infrastructure, with COVID-19 and comparative international health metrics as key use cases.
Both projects are CSA-type coordination actions where the ministry's explicit function is to link EU-level policy initiatives to Lithuanian national health system structures.
PHIRI keywords include metadata, data models, and international comparisons, indicating involvement in standardizing how national health datasets are described and made comparable across EU member states.
Both projects started in 2020, so the timeline is compressed — but the thematic shift between the two is meaningful. The earlier engagement (X-eHealth) is focused on clinical data exchange: structured records, hospital reports, lab results, imaging, and rare diseases — essentially the infrastructure layer of individual patient data moving across borders. The second project (PHIRI) pivots toward aggregate, population-level data: COVID-19 surveillance, comparative public health metrics, research infrastructure, and data models for health research. This suggests a ministry that entered EU collaboration through clinical interoperability and then broadened its scope toward public health analytics and research governance — a trajectory consistent with the COVID-19 era forcing national health authorities to think at population scale.
The ministry is moving from clinical data standards toward population health research infrastructure, suggesting future interest in EU health data spaces, secondary use of health data, and cross-border public health surveillance initiatives.
The ministry has never led an H2020 project — both participations are as a partner in large CSA consortia. Despite receiving modest direct funding (EUR 41,000 total), it operates within very large networks: 66 distinct partners across 31 countries from just two projects, which is a hallmark of pan-European policy coordination actions that aggregate national authorities. This tells potential partners they can expect the ministry to contribute national data access and policy legitimacy rather than research capacity or technical development work.
With 66 unique consortium partners across 31 countries from only two projects, the ministry is embedded in exceptionally broad EU health networks. This footprint reflects the pan-European character of both CSA projects, which by design recruit health ministries and agencies from across all EU member states.
As Lithuania's central health authority, the ministry offers something no research institute or hospital can replicate: the legal and regulatory mandate to commit national health data systems to EU interoperability frameworks. Consortia building projects that need an official national competent authority from the Baltic region — particularly for eHealth, EHR exchange, or population health surveillance — will find the ministry a credible and necessary partner. Its value is specifically governmental: access, authority, and policy commitment, not research output.
